Geron (GERN)

$2.89 1%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    5
  • Fundamental

    9
  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Geron, AI stock picks, stock alerts and much more.

Sign up

GERN AI Stock Analysis

AI stock analysis for GERN is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Geron (GERN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

GERN Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Geron (GERN), currently trading at $2.89, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About GERN

LSE
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies.

  • Symbol

    GERN

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    1.7B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX
$22.78
0.5%
6
INO Inovio Pharmaceuticals
INO
$2.08
8.9%
4
MRNA Moderna
MRNA
$34.06
0.9%
4
AVXL Anavex Life Sciences
AVXL
$9.21
9.3%
6
BBIO BridgeBio Pharma
BBIO
$33.79
0.9%
7

GERN Alternative Data

News Mentions

Sign up to access

LinkedIn Followers

Sign up to access

Job Postings

Sign up to access

LinkedIn Employees

Sign up to access

Web Traffic

Sign up to access

Business Outlook

Sign up to access

GERN Financials

GERN Key Metrics
  • Total Revenue

    $28.3M

  • Net Income

    -$26.4M

  • Earnings per Share

    -$0.0399

  • Free cash flow

    -$58.9M

  • EBITDA

    -$23.2M

  • EBITDA Ratio

    -0.820629

  • Total Assets

    $402.7M

GERN 2-year Revenue & Income
GERN 2-year Free Cash Flow

GERN Technicals

GERN SMA
GERN RSI

FAQ

What's the current price of Geron (GERN) Stock?
The price of an Geron (GERN) share is $2.89.

What's the market cap of Geron?
The current market cap of Geron is 1.7B.

Should I buy or sell GERN?
Geron shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Geron is better viewed as a hold or accumulate position while waiting for further developments.

Is Geron a good investment?
The current analysis of Geron's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Geron's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Geron (GERN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Geron stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Geron (GERN) that investors often compare it to?
Geron (GERN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Geron's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Geron's stock price to be around $2.99 in 2026. Starting from the current price of $2.89, this represents a 3.3% change in price, indicating a neutral outlook for the stock.

How to buy Geron (GERN) Stock?
Geron stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Geron shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.